Unique ID issued by UMIN | UMIN000033142 |
---|---|
Receipt number | R000037040 |
Scientific Title | Accompanying research of Phase II study of atezolizumab for advanced non-small-cell lung cancer patients not indicative of cytotoxic chemotherapy |
Date of disclosure of the study information | 2018/07/07 |
Last modified on | 2021/06/27 22:12:12 |
Accompanying research of Phase II study of atezolizumab for advanced non-small-cell lung cancer patients not indicative of cytotoxic chemotherapy
2130-A
Accompanying research of Phase II study of atezolizumab for advanced non-small-cell lung cancer patients not indicative of cytotoxic chemotherapy
2130-A
Japan |
advanced non-small cell lung cancer
Pneumology |
Malignancy
NO
To explore the relationship between treatment outcome and PBMC or cytokines of previously treated with advanced NSCLC who enrolled onto nivolumab trial (XXXX trial). XXXX trial is a Phase II safety and efficacy study of atezolizumab in poor performance status patients with previously treated advanced NSCLC in Tokyo Metropolitan Komagome Hospital. The UMIN ID of XXXX trial is UMINXXXXX.
Efficacy
Exploratory
Explanatory
Phase II
To explore the relationship between immunological state of atezolizumab treated patients having NSCLC with poor performance status
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1) Patients enrolled onto the Phase II safety and efficacy study of atezolizumab in poor performance status patients with previously treated advanced NSCLC (UMIN000032585)
2) Patients providing written informed consent.
None
64
1st name | Yukio |
Middle name | |
Last name | Hosomi |
Tokyo Metropolitan Komagome Hospital
Department of Thoracic Oncology and Respiratory Medicine
113-8677
3-18-22, Honkomagome, Bunkyo, Tokyo, JAPAN
+81-03-3823-2101
yhosomi@cick.jp
1st name | Yusuke |
Middle name | |
Last name | Okuma |
Tokyo Metropolitan Komagome Hospital
Department of Thoracic Oncology and Respiratory Medicine
113-8677
3-18-22, Honkomagome, Bunkyo, Tokyo, JAPAN
+81-03-3823-2101
y-okuma@cick.jp
partment of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Komagome Hospital
Self funding
Self funding
National Cancer Center Hospital
Ethics committee of Tokyo Metropolitan Komagome Hospital
3-28-22, Honkomagome, Bunkyo, Tokyo
03-3823-2101
rinri@cick.jp
NO
2018 | Year | 07 | Month | 07 | Day |
Unpublished
Terminated
2018 | Year | 06 | Month | 25 | Day |
2018 | Year | 06 | Month | 25 | Day |
2018 | Year | 06 | Month | 25 | Day |
2021 | Year | 05 | Month | 31 | Day |
None
2018 | Year | 06 | Month | 25 | Day |
2021 | Year | 06 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037040
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |